Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Sarah Milgrom

Concepts (347)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hodgkin Disease
34
2024
133
9.560
 Why?
Radiotherapy, Intensity-Modulated
15
2024
129
3.260
 Why?
Positron Emission Tomography Computed Tomography
14
2023
84
2.950
 Why?
Tumor Burden
6
2024
286
2.300
 Why?
Fluorodeoxyglucose F18
7
2023
128
2.290
 Why?
Antineoplastic Combined Chemotherapy Protocols
30
2024
1556
2.170
 Why?
Lymphoma
9
2024
196
2.090
 Why?
Radiotherapy
12
2020
185
1.930
 Why?
Central Nervous System Neoplasms
9
2021
146
1.860
 Why?
Radiation Injuries
8
2021
135
1.830
 Why?
Radiopharmaceuticals
6
2023
168
1.750
 Why?
Radiotherapy Planning, Computer-Assisted
12
2024
124
1.700
 Why?
Lymphoma, Non-Hodgkin
6
2024
77
1.610
 Why?
Neoplasm Staging
30
2021
1290
1.500
 Why?
Lymphoma, Large B-Cell, Diffuse
8
2024
112
1.470
 Why?
Radiotherapy Dosage
16
2024
251
1.350
 Why?
Neoplasm Recurrence, Local
13
2023
958
1.350
 Why?
Sarcoma
2
2023
176
1.320
 Why?
Salvage Therapy
11
2024
133
1.270
 Why?
Endometrial Neoplasms
4
2014
164
1.190
 Why?
Mediastinal Neoplasms
5
2021
38
1.180
 Why?
Hematopoietic Stem Cell Transplantation
7
2024
572
1.150
 Why?
Combined Modality Therapy
22
2024
1199
1.110
 Why?
Whole-Body Irradiation
2
2024
76
1.060
 Why?
Radiotherapy, Adjuvant
7
2024
208
1.050
 Why?
Prognosis
22
2023
3773
1.000
 Why?
Rhabdomyosarcoma
2
2024
64
0.990
 Why?
Positron-Emission Tomography
8
2024
286
0.970
 Why?
Neoplasms
4
2024
2449
0.960
 Why?
Sarcoma, Ewing
2
2024
88
0.950
 Why?
Disease Progression
7
2024
2630
0.910
 Why?
Humans
109
2025
129266
0.890
 Why?
Radiation
2
2020
23
0.850
 Why?
Craniopharyngioma
1
2024
74
0.850
 Why?
Radiation Exposure
1
2023
45
0.830
 Why?
Hematologic Neoplasms
1
2025
140
0.820
 Why?
Pituitary Neoplasms
1
2024
179
0.810
 Why?
Adenocarcinoma
3
2014
898
0.800
 Why?
Lymphoma, Follicular
5
2020
38
0.790
 Why?
Salivary Glands
2
2021
29
0.770
 Why?
Retrospective Studies
38
2024
14461
0.760
 Why?
Smiling
1
2021
6
0.760
 Why?
Xerostomia
1
2021
17
0.740
 Why?
Tooth Abnormalities
1
2021
13
0.730
 Why?
Brachytherapy
1
2021
104
0.710
 Why?
Young Adult
32
2025
12391
0.680
 Why?
Chemoradiotherapy
9
2021
208
0.680
 Why?
Proton Therapy
1
2020
12
0.680
 Why?
Face
1
2021
165
0.670
 Why?
Child
21
2025
20785
0.670
 Why?
Aged
41
2020
22032
0.660
 Why?
Aged, 80 and over
21
2020
7055
0.650
 Why?
Intraocular Lymphoma
2
2016
3
0.640
 Why?
Doxorubicin
12
2020
328
0.640
 Why?
Middle Aged
49
2024
31090
0.640
 Why?
Bleomycin
8
2020
242
0.620
 Why?
Rectal Neoplasms
3
2016
136
0.610
 Why?
Lymphoma, B-Cell, Marginal Zone
4
2019
12
0.610
 Why?
Adult
51
2024
35495
0.600
 Why?
Vinblastine
8
2020
70
0.590
 Why?
Cerebellar Neoplasms
1
2020
151
0.590
 Why?
Dacarbazine
8
2020
93
0.580
 Why?
Medulloblastoma
1
2020
192
0.580
 Why?
Recurrence
9
2020
1005
0.550
 Why?
Meningeal Neoplasms
1
2018
92
0.530
 Why?
Leukemia, Myeloid, Acute
2
2023
592
0.530
 Why?
Leukemia, Biphenotypic, Acute
1
2016
3
0.530
 Why?
Cancer Survivors
1
2021
257
0.530
 Why?
Adolescent
26
2025
20313
0.520
 Why?
Patient Satisfaction
1
2020
632
0.510
 Why?
Head and Neck Neoplasms
1
2021
543
0.500
 Why?
Female
56
2024
68551
0.500
 Why?
Breast Neoplasms
5
2019
2140
0.490
 Why?
Treatment Outcome
25
2024
10202
0.490
 Why?
Graft vs Host Disease
2
2024
240
0.490
 Why?
Brain Neoplasms
3
2023
1143
0.490
 Why?
Eye Diseases
1
2016
81
0.480
 Why?
Survival Rate
12
2021
1869
0.460
 Why?
Male
50
2024
63512
0.450
 Why?
Disease-Free Survival
12
2020
645
0.440
 Why?
Consensus
4
2024
615
0.440
 Why?
Follow-Up Studies
15
2020
4887
0.440
 Why?
Glycolysis
3
2023
311
0.430
 Why?
Endometrium
1
2013
60
0.420
 Why?
Peritoneal Cavity
1
2013
31
0.420
 Why?
Stomach Neoplasms
3
2019
99
0.420
 Why?
Digestive System Surgical Procedures
1
2014
96
0.420
 Why?
Lymphoma, B-Cell
3
2021
105
0.410
 Why?
Palate, Hard
1
2012
5
0.410
 Why?
Infertility, Female
1
2013
99
0.400
 Why?
Chemoradiotherapy, Adjuvant
3
2019
41
0.400
 Why?
Image Enhancement
1
2013
167
0.400
 Why?
Mastectomy, Simple
1
2012
1
0.400
 Why?
Neoadjuvant Therapy
2
2016
381
0.390
 Why?
Carcinoma, Lobular
1
2012
48
0.380
 Why?
Sentinel Lymph Node Biopsy
1
2012
107
0.370
 Why?
Carcinoma, Ductal, Breast
1
2012
82
0.370
 Why?
Adrenal Gland Neoplasms
1
2012
84
0.360
 Why?
Organs at Risk
3
2020
31
0.350
 Why?
Disease Management
6
2019
588
0.330
 Why?
Tomography, X-Ray Computed
7
2023
2515
0.330
 Why?
Biopsy
6
2020
1092
0.330
 Why?
Radiotherapy, Image-Guided
3
2019
34
0.330
 Why?
Cellulitis
1
2009
48
0.320
 Why?
Carcinoma, Squamous Cell
1
2014
625
0.310
 Why?
Kaplan-Meier Estimate
7
2020
851
0.310
 Why?
Lymphocytes
3
2020
378
0.300
 Why?
Lymphoma, Mantle-Cell
2
2019
19
0.300
 Why?
Multiple Myeloma
2
2020
125
0.290
 Why?
Survival Analysis
6
2020
1269
0.260
 Why?
Cardiotoxicity
2
2023
33
0.260
 Why?
Pregnancy Complications, Neoplastic
2
2017
53
0.260
 Why?
Patient Selection
2
2022
662
0.260
 Why?
Testicular Neoplasms
2
2018
103
0.250
 Why?
Radiation Pneumonitis
2
2016
28
0.250
 Why?
Heart
3
2018
637
0.240
 Why?
Risk Assessment
6
2023
3232
0.240
 Why?
Lymph Node Excision
2
2019
164
0.240
 Why?
Child, Preschool
5
2024
10459
0.240
 Why?
Antimetabolites, Antineoplastic
2
2017
91
0.230
 Why?
Magnetic Resonance Imaging
4
2019
3386
0.230
 Why?
Leukemia
2
2017
229
0.230
 Why?
Transplantation, Haploidentical
1
2024
21
0.230
 Why?
Central Nervous System
3
2021
253
0.220
 Why?
Mediastinum
3
2019
24
0.220
 Why?
Risk Factors
5
2021
9745
0.220
 Why?
Lymphatic Metastasis
3
2014
320
0.210
 Why?
Lymphadenopathy
1
2023
9
0.210
 Why?
Antineoplastic Agents
5
2024
2054
0.210
 Why?
Cord Blood Stem Cell Transplantation
1
2024
99
0.210
 Why?
Transplantation Conditioning
1
2024
166
0.210
 Why?
Neoplasm Grading
4
2019
283
0.200
 Why?
Remission Induction
3
2018
271
0.200
 Why?
Postoperative Complications
1
2014
2473
0.200
 Why?
Protons
2
2020
80
0.200
 Why?
Cohort Studies
6
2024
5409
0.190
 Why?
Brain Stem Neoplasms
1
2023
81
0.190
 Why?
Bone Neoplasms
1
2024
231
0.190
 Why?
Chemotherapy, Adjuvant
2
2013
379
0.190
 Why?
Radiometry
2
2019
47
0.190
 Why?
Gastric Mucosa
2
2019
52
0.190
 Why?
Transplantation, Autologous
3
2018
211
0.190
 Why?
Survivors
2
2023
457
0.190
 Why?
Mitogen-Activated Protein Kinase 7
1
2021
21
0.190
 Why?
Multimodal Imaging
3
2017
110
0.180
 Why?
Poly(ADP-ribose) Polymerases
1
2021
94
0.180
 Why?
Radium
1
2020
3
0.180
 Why?
Breath Holding
2
2017
7
0.180
 Why?
Long Term Adverse Effects
1
2020
12
0.180
 Why?
Cranial Irradiation
2
2023
67
0.170
 Why?
Lung Neoplasms
2
2024
2342
0.170
 Why?
Cardiology
1
2022
261
0.160
 Why?
Stem Cell Transplantation
2
2018
164
0.160
 Why?
Clinical Trials as Topic
1
2024
1004
0.160
 Why?
Postoperative Care
2
2019
241
0.160
 Why?
Skin Neoplasms
2
2018
824
0.160
 Why?
Plasmacytoma
1
2019
16
0.160
 Why?
Radiation Dosage
1
2020
153
0.160
 Why?
CD4-CD8 Ratio
1
2018
22
0.160
 Why?
Glioma
1
2023
347
0.150
 Why?
Mycosis Fungoides
1
2018
61
0.150
 Why?
Methotrexate
2
2017
248
0.150
 Why?
Electrons
1
2018
77
0.150
 Why?
Area Under Curve
1
2019
304
0.150
 Why?
Breast Neoplasms, Male
1
2018
29
0.150
 Why?
Peritoneal Neoplasms
1
2019
87
0.150
 Why?
Radiotherapy Setup Errors
1
2017
3
0.140
 Why?
Platelet Count
1
2017
82
0.140
 Why?
Autografts
1
2018
42
0.140
 Why?
Hypothyroidism
1
2018
70
0.140
 Why?
Craniospinal Irradiation
1
2017
5
0.140
 Why?
Dendritic Cell Sarcoma, Follicular
1
2017
2
0.140
 Why?
Eye Neoplasms
1
2017
16
0.140
 Why?
Vincristine
4
2019
108
0.140
 Why?
Uncertainty
1
2017
116
0.140
 Why?
Leukocyte Count
1
2017
326
0.140
 Why?
Osteogenesis Imperfecta
2
2007
13
0.130
 Why?
Spinal Cord Diseases
1
2017
40
0.130
 Why?
Pentostatin
1
2016
1
0.130
 Why?
Neoplasm, Residual
1
2017
120
0.130
 Why?
Axilla
2
2017
45
0.130
 Why?
Photopheresis
1
2016
9
0.130
 Why?
Predictive Value of Tests
3
2022
1949
0.130
 Why?
Collagen Type I
2
2007
118
0.130
 Why?
Methylprednisolone
1
2016
83
0.130
 Why?
Radiographic Image Interpretation, Computer-Assisted
1
2016
99
0.130
 Why?
Plasmablastic Lymphoma
1
2015
7
0.130
 Why?
Confidence Intervals
1
2016
316
0.130
 Why?
Anxiety
1
2023
962
0.120
 Why?
Antibiotics, Antineoplastic
1
2016
123
0.120
 Why?
Congenital Abnormalities
1
2016
74
0.120
 Why?
Abortion, Spontaneous
1
2016
100
0.120
 Why?
Drug Resistance, Neoplasm
2
2019
756
0.120
 Why?
Fatal Outcome
1
2016
299
0.120
 Why?
Hysterectomy
2
2013
118
0.120
 Why?
Proportional Hazards Models
4
2020
1197
0.120
 Why?
Transplantation, Homologous
1
2016
400
0.120
 Why?
Tacrolimus
1
2016
193
0.120
 Why?
Coronary Artery Disease
1
2021
679
0.120
 Why?
Blood Platelets
1
2017
380
0.110
 Why?
Biomarkers
4
2021
3968
0.110
 Why?
Risk
1
2016
854
0.110
 Why?
Age Factors
1
2021
3140
0.110
 Why?
Etoposide
3
2018
148
0.110
 Why?
Receptors, Progesterone
2
2014
343
0.110
 Why?
Kidney Neoplasms
1
2018
348
0.110
 Why?
Cyclophosphamide
3
2019
232
0.110
 Why?
Receptor, ErbB-2
2
2014
326
0.110
 Why?
Rituximab
3
2019
164
0.100
 Why?
Caregivers
1
2020
809
0.100
 Why?
Spinal Cord
1
2015
353
0.100
 Why?
Carboplatin
1
2013
139
0.100
 Why?
Receptors, Estrogen
2
2014
426
0.100
 Why?
Lung
2
2016
3927
0.100
 Why?
Carcinoma, Non-Small-Cell Lung
1
2021
1049
0.100
 Why?
Anti-Inflammatory Agents
1
2016
480
0.100
 Why?
Pelvis
1
2013
104
0.100
 Why?
Fluorouracil
1
2013
198
0.100
 Why?
Radiotherapy, Conformal
1
2012
69
0.100
 Why?
Paclitaxel
1
2013
217
0.100
 Why?
Neutrophils
1
2017
1207
0.100
 Why?
Health Knowledge, Attitudes, Practice
1
2020
1276
0.100
 Why?
Immunoenzyme Techniques
1
2012
214
0.090
 Why?
Immunohistochemistry
1
2016
1691
0.090
 Why?
Immunosuppressive Agents
1
2016
854
0.090
 Why?
Cisplatin
1
2013
299
0.090
 Why?
Brain
2
2020
2669
0.090
 Why?
Immunotherapy
1
2015
592
0.090
 Why?
Triple Negative Breast Neoplasms
1
2014
197
0.090
 Why?
Models, Biological
1
2018
1722
0.090
 Why?
Contrast Media
1
2013
393
0.090
 Why?
Liver Neoplasms
1
2014
640
0.080
 Why?
Prospective Studies
3
2021
7123
0.080
 Why?
Patient Compliance
1
2013
563
0.080
 Why?
Polymorphism, Single Nucleotide
1
2016
2063
0.080
 Why?
Dose-Response Relationship, Radiation
2
2020
132
0.080
 Why?
Antibodies, Monoclonal, Murine-Derived
2
2019
87
0.070
 Why?
United States
2
2021
13826
0.070
 Why?
Biomarkers, Tumor
1
2014
1173
0.070
 Why?
Prednisone
2
2019
233
0.070
 Why?
Colorectal Neoplasms
1
2014
752
0.070
 Why?
Cytarabine
2
2018
57
0.070
 Why?
Practice Guidelines as Topic
1
2014
1497
0.070
 Why?
Time Factors
4
2018
6543
0.070
 Why?
Proteoglycans
1
2007
109
0.070
 Why?
Integrins
1
2007
94
0.060
 Why?
Treatment Failure
2
2018
339
0.060
 Why?
Glycine
1
2006
165
0.060
 Why?
Amino Acid Substitution
1
2006
282
0.060
 Why?
Clinical Decision-Making
2
2019
301
0.060
 Why?
Neoplasm Invasiveness
2
2017
483
0.060
 Why?
X-ray Repair Cross Complementing Protein 1
1
2023
13
0.050
 Why?
Intelligence Tests
1
2023
57
0.050
 Why?
Standard of Care
1
2024
71
0.050
 Why?
X-Rays
1
2023
27
0.050
 Why?
Cell- and Tissue-Based Therapy
1
2024
76
0.050
 Why?
Regression Analysis
2
2016
991
0.050
 Why?
Proto-Oncogene Proteins c-sis
1
2023
35
0.050
 Why?
Terminology as Topic
1
2024
203
0.050
 Why?
Inducible T-Cell Co-Stimulator Protein
1
2022
9
0.050
 Why?
Analysis of Variance
2
2016
1288
0.050
 Why?
Phenotype
3
2021
3074
0.050
 Why?
Cytidine Deaminase
1
2023
57
0.050
 Why?
Brain Stem
1
2023
98
0.050
 Why?
Ribose
1
2021
22
0.050
 Why?
Radiosurgery
1
2024
320
0.050
 Why?
Adenosine Diphosphate
1
2021
80
0.050
 Why?
Poly (ADP-Ribose) Polymerase-1
1
2021
42
0.050
 Why?
Troponin T
1
2021
57
0.050
 Why?
Feedback
1
2021
162
0.040
 Why?
Immunotherapy, Adoptive
1
2024
295
0.040
 Why?
Automation
1
2020
81
0.040
 Why?
Neoplasms, Radiation-Induced
1
2020
71
0.040
 Why?
Prevalence
2
2016
2553
0.040
 Why?
Risk Management
1
2020
85
0.040
 Why?
Incidence
2
2016
2636
0.040
 Why?
Neoplasms, Second Primary
1
2020
106
0.040
 Why?
Workflow
1
2020
155
0.040
 Why?
Neuropsychological Tests
1
2023
1014
0.040
 Why?
Mesentery
1
2019
47
0.040
 Why?
Safety
1
2020
330
0.040
 Why?
Busulfan
1
2018
15
0.040
 Why?
Melphalan
1
2018
29
0.040
 Why?
Respiration
1
2019
191
0.040
 Why?
Carmustine
1
2018
50
0.040
 Why?
Inhalation
1
2017
28
0.040
 Why?
Cone-Beam Computed Tomography
1
2017
30
0.040
 Why?
Subacute Combined Degeneration
1
2017
1
0.030
 Why?
Time-to-Treatment
1
2019
179
0.030
 Why?
Breast
1
2018
153
0.030
 Why?
Photons
1
2017
64
0.030
 Why?
Organ Sparing Treatments
1
2017
32
0.030
 Why?
Phosphorylation
1
2021
1710
0.030
 Why?
Deoxycytidine
1
2018
165
0.030
 Why?
Injections, Spinal
1
2017
104
0.030
 Why?
Orbit
1
2017
57
0.030
 Why?
Lymph Nodes
1
2019
470
0.030
 Why?
New York
1
2016
128
0.030
 Why?
Homocysteine
1
2017
152
0.030
 Why?
Procarbazine
1
2015
8
0.030
 Why?
Transforming Growth Factor beta1
1
2016
157
0.030
 Why?
Mutation
1
2007
3710
0.030
 Why?
Observer Variation
1
2016
315
0.030
 Why?
Genetic Markers
1
2016
336
0.030
 Why?
Animals
2
2021
35309
0.030
 Why?
Folic Acid
1
2017
184
0.030
 Why?
Texas
1
2016
228
0.030
 Why?
Mitochondria
1
2021
877
0.030
 Why?
Secondary Prevention
1
2016
218
0.030
 Why?
Molecular Targeted Therapy
1
2018
390
0.030
 Why?
Gastrointestinal Diseases
1
2016
198
0.030
 Why?
Pregnancy Outcome
1
2017
389
0.030
 Why?
Diagnostic Imaging
1
2017
327
0.030
 Why?
Abortion, Induced
1
2016
100
0.030
 Why?
Pregnancy
2
2017
6390
0.030
 Why?
Drug Administration Schedule
1
2016
768
0.030
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
278
0.030
 Why?
Acute Disease
1
2016
978
0.030
 Why?
Postpartum Period
1
2016
332
0.030
 Why?
Mastectomy
1
2014
131
0.030
 Why?
CD8-Positive T-Lymphocytes
1
2018
857
0.030
 Why?
Ultrasonography
1
2016
713
0.020
 Why?
Multivariate Analysis
1
2016
1497
0.020
 Why?
Diagnosis, Differential
1
2017
1432
0.020
 Why?
CD4-Positive T-Lymphocytes
1
2018
1056
0.020
 Why?
Medical Oncology
1
2014
270
0.020
 Why?
Ovariectomy
1
2012
135
0.020
 Why?
Comorbidity
1
2016
1544
0.020
 Why?
Severity of Illness Index
1
2019
2740
0.020
 Why?
Quality of Life
1
2021
2687
0.020
 Why?
Electronic Health Records
1
2017
970
0.020
 Why?
Kidney
1
2017
1385
0.020
 Why?
Diet
1
2017
1212
0.020
 Why?
Reproducibility of Results
1
2016
3080
0.020
 Why?
Anti-Bacterial Agents
1
2019
1708
0.020
 Why?
Genetic Predisposition to Disease
1
2016
2276
0.020
 Why?
Infant
1
2020
8975
0.020
 Why?
Electrophoresis
1
2006
30
0.020
 Why?
Case-Control Studies
1
2014
3377
0.020
 Why?
DNA Mutational Analysis
1
2007
385
0.020
 Why?
Databases, Genetic
1
2007
230
0.020
 Why?
Collagen
1
2007
433
0.010
 Why?
Protein Structure, Tertiary
1
2007
841
0.010
 Why?
Mice
1
2021
16915
0.010
 Why?
Binding Sites
1
2007
1250
0.010
 Why?
Protein Binding
1
2007
2120
0.010
 Why?
Cells, Cultured
1
2006
4077
0.010
 Why?
Milgrom's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (347) concept(s)
_
Co-Authors Expand Description
See all (36) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)